Market Outlook reports bring together epidemiology, treatment dynamics, pricing, pipeline, and competition into one forecast you can plan around.
Revenue forecast, 2026 to 2036
Example indication, 8 major markets, $B
Illustrative data
New entrants take the largest share by 2036 as standard of care declines.
The US stays the largest market; China grows fastest from a small base.
Five connected views of every patient population, all from one traceable data set.
Chapter 1
Causes, classification, and how the disease progresses
Chapter 2
Incidence, prevalence, and diagnosed and treated patients
Chapter 3
How patients split across therapies and segments
Chapter 4
Guidelines and real-world treatment patterns
Chapter 5
Which therapies are used, and how often
Chapter 6
Share of prescriptions by drug and class
Chapter 7
Marketed and pipeline therapies, with launch timing
Chapter 8
Chapter 9
Expected uptake of new entrants over time
Chapter 10
Market value by therapy class and brand, 2026 to 2036
Chapter 11
What the numbers mean for your strategy
10 to 15 year projections with scenario modelling
Diagnosed, treated, and eligible patients by market
Forecasts by therapy class and by individual brand
Share changes, loss of exclusivity, and biosimilar impact
The forces that speed up or slow down growth
Input for commercial planning and business development
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036
Our Market Forecasting team builds custom, patient-based models, with epidemiology from EpiLansis
8 major markets · 2026 to 2036
We'll email a sample of a report, to within one business day.
Validated patient numbers, trends, and disease burden by market.
The pipeline, the gaps it must fill, and the profile that wins.
Pricing, HTA, and reimbursement paths in each market.
Each forecast combines epidemiology, treatment dynamics, pricing, pipeline intelligence, and competitive change, then models how the market evolves over 10 to 15 years.
Our Market Outlook reports cover 8 major markets: the US, Germany, France, Italy, Spain, the UK, Japan, and China.
Yes. We can adjust scope, markets, or segments, or build a custom forecast through our Market Forecasting team.
Yes. We can adjust scope, markets, or segments, or build a custom forecast through our Market Forecasting team.
Reports give you a ready-made view of a whole market. Our consulting team builds a forecast around your own asset, assumptions, and decisions.
Turn data into decision-ready intelligence with EpiLansis.
Or call +91 124 493 7605, Monday to Friday, 08:00 to 20:00
Fill in your details and our expert consultants will get in touch with you.
